Tumors under periodic therapy -- Role of the immune response time delay
D. Rodriguez-Perez, Oscar Sotolongo-Grau, Ramon Espinosa Riquelme, Oscar Sotolongo-Costa, J. Antonio Santos Miranda, J. C. Antoranz
Abstract
We model the interaction between the immune system and tumor cells including a time delay to simulate the time needed by the latter to develop a chemical and cell mediated response to the presence of the tumor. The results are compared with those of a previous paper, concluding that the delay introduces new instabilities in the system leading to an uncontrolable growth of the tumour. Then a cytokine based periodic immunotherapy treatment is included in the model and the effects of its dossage are studied for the case of a weak immune system and a growing tumour. We find the existence of metastable states (that may last for tens of years) induced by the treatment, and also of potentially adverse effects of the dossage frequency on the stabilization of the tumour. These two effects depend on the delay, the cytokine dose burden and other parameters considered in the model.
Create a lesson
Related papers
Adaptive therapy under parametric, structural, and measurement uncertainty
Alexander P Browning, Rebecca M Crossley, Ryan J Murphy et al.
Head Impact Characterization and Cellular Response of a Live-neuron cell-integrated Biomechanical Full-body Surrogate Model
Raisa Akhtaruzzaman, Mohammad Ibrahim Hossain, Rahid Zaman et al.
History Matters: Damage-Mediated Amplification of Brain Deformation and Injury Risk under Repeated Head Impacts
Carson Cooper, Anu Tripathi, Genevieve Palardy et al.
Poisson Flow and Wasserstein Registration of Trees
Moo K. Chung
A microscopic computational simulation of [18F]FDG transport and metabolism identifies valid regimes for compartmental analysis
Xiaoxu Zhong, Guillem Pratx
Environmental and cell-cell signaling shape developmental trajectories across morphogenetic landscapes
J. Hareesh, Sitabhra Sinha